{
    "url_original": "https://www.wsj.com/articles/merck-ridgeback-covid-19-pill-cleared-for-use-in-u-k-11636023388?mod=business_lead_pos1",
    "url": "merck-ridgeback-covid-19-pill-cleared-for-use-in-u-k-11636023388",
    "title": "Merck Covid-19 Pill Cleared for Use in U.K.",
    "sub_head": "U.S. is also expected to authorize molnupiravir, which has been found to reduce the risk of hospitalization, in coming months",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-425600?width=860&height=573",
    "image_1": "im-425600.jpg",
    "time": "2021-11-04 06:56:00",
    "body": "Merck  & Co. said U.K. health regulators cleared a Covid-19 drug it developed with partner Ridgeback Biotherapeutics LP, the first country to authorize the pill that can be taken at home and promises to keep people out of the hospital.<br />The Merck-Ridgeback drug will give the U.K. a much-needed weapon against Covid-19 as winter approaches."
}